The Protecting Patients from Deceptive Drug Ads Online Act aims to crack down on social media influencers and others who make misleading comments about pharmaceutical drugs. Introduced in the U.S. Senate, the bill would allow the FDA to issue warnings and fines to those promoting prescription drugs with false information. Medical professionals support the bill, stating that transparency in drug advertising is crucial for patient safety. The legislation targets false or misleading communications on social media about FDA-approved medications. Overall, the bill aims to combat online misinformation about prescription drugs, especially in the context of obesity medications.
Source link
Senate bill aims to curtail social media influencer, telehealth drug misinformation
